Ignite Creation Date:
2024-05-06 @ 3:06 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04529239
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2020-08-24
Brief Title:
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System
Sponsor:
Klick Inc
Organization:
Klick Inc
Study Overview
Official Title:
A Triple Cohort Prospective Observational Study to Analyze Type 2 Diabetes Glucose Biomarkers With a Continuous Glucose Monitoring System
Status:
COMPLETED
Status Verified Date:
2020-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Current gold standard methodologies for diagnosing type 2 diabetes T2D or prediabetes can be unreliable and inaccurate and require the need for multiple different tests for comparison It is possible that a simpler and more refined method of diagnosing T2D or prediabetes involves examining the proportional-integral PI control system of the bodys glycemic function ie a model of the glucose curve The purpose of this research is to examine how well a PI model can diagnose nondiabetic prediabetic or diabetic patients based on glucose data gathered from a wearable glucose monitoring device
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None